Evaluation of the possible benefits of post-radiotherapy surgery after concomitant chemoradiotherapy with a new radio-sensitizing regimen (irinotecan / CPT-11, interferon A2b and amifostine) for advanced-stage cervical carcinoma. Preliminary results of a pilot phase-II study. [electronic resource]
Producer: 20090917Description: 197-202 p. digitalISSN:- 1107-0625
- Adult
- Aged
- Aged, 80 and over
- Amifostine -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Camptothecin -- administration & dosage
- Carcinoma, Adenosquamous -- drug therapy
- Carcinoma, Squamous Cell -- drug therapy
- Combined Modality Therapy
- Feasibility Studies
- Female
- Humans
- Interferon alpha-2
- Interferon-alpha -- administration & dosage
- Irinotecan
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Pilot Projects
- Preoperative Care
- Prognosis
- Radiotherapy Dosage
- Recombinant Proteins
- Survival Rate
- Treatment Outcome
- Uterine Cervical Neoplasms -- drug therapy
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.